- €2.11bn
- €3.62bn
- €2.03bn
- 48
- 85
- 47
- 65
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,984 | 1,876 | 1,782 | 1,944 | 2,030 |
Cost of Revenue | |||||
Gross Profit | 1,715 | 1,597 | 1,514 | 1,596 | 1,596 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,619 | 1,794 | 1,314 | 1,804 | 2,716 |
Operating Profit | 365 | 82 | 468 | 140 | -686 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 200 | -102 | 397 | 52 | -728 |
Provision for Income Taxes | |||||
Net Income After Taxes | 276 | -95 | 446 | -35 | -904 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 296 | -86 | 453 | -34 | -905 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 247 | -135 | 412 | -70 | -941 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.709 | 0.347 | 1.15 | 0.281 | 0.03 |
Dividends per Share |